These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9820463)

  • 1. Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start?
    Levey AS
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S5-13. PubMed ID: 9820463
    [No Abstract]   [Full Text] [Related]  

  • 2. Methods of literature review and synthesis.
    Coronado BE; Bu D; Levey AS; Meyer KB
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S14-55. PubMed ID: 9820464
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening and treatment for cardiovascular disease in patients with chronic renal disease.
    Murphy SW; Foley RN; Parfrey PS
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S184-99. PubMed ID: 9820475
    [No Abstract]   [Full Text] [Related]  

  • 4. Inappropriately high left ventricular mass: marker of very high cardiovascular risk in patients with chronic kidney disease?
    Nardi E; Palermo A; Mulè G
    Hypertens Res; 2012 Aug; 35(8):800-1. PubMed ID: 22573199
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
    Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):458-63. PubMed ID: 15854551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anemia and cardiovascular risk in the patient with kidney disease.
    Fishbane S
    Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease.
    Meyer KB; Levey AS
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S31-42. PubMed ID: 11443766
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency.
    Das M; Aronow WS; McClung JA; Belkin RN
    Cardiol Rev; 2006; 14(1):14-7. PubMed ID: 16371761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S112-9. PubMed ID: 9820470
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemoglobin levels, cardiovascular disease, and left ventricular hypertrophy in patients with chronic kidney disease. Case study of the anemic patient.
    Butler KG
    Nephrol Nurs J; 2002 Apr; 29(2):189-92. PubMed ID: 11997954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy in renal failure a review.
    Arodiwe EB
    Niger J Clin Pract; 2007 Mar; 10(1):83-90. PubMed ID: 17668722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease as a cardiovascular risk factor.
    Best PJ; Holmes DR
    Am Heart J; 2003 Mar; 145(3):383-6. PubMed ID: 12660658
    [No Abstract]   [Full Text] [Related]  

  • 13. The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease.
    Chen SC; Chang JM; Liu WC; Chen YY; Chen LI; Huang JC; Yang TK; Su HM; Chen HC
    Hypertens Res; 2012 Aug; 35(8):832-8. PubMed ID: 22456347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume control and left ventricular hypertrophy in patients with end-stage renal disease.
    De Francisco AL; Piñera C
    Int J Artif Organs; 2004 Feb; 27(2):83-7. PubMed ID: 15061470
    [No Abstract]   [Full Text] [Related]  

  • 15. Ventricular arrhythmias and sudden cardiac death in end-stage renal disease patients on chronic hemodialysis.
    Meier P; Vogt P; Blanc E
    Nephron; 2001 Mar; 87(3):199-214. PubMed ID: 11287755
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients.
    Washio M; Okuda S; Mizoue T; Kiyama S; Ando T; Sanai T; Hirakata H; Nanishi F; Kiyohara C; Ogimoto I; Yoshimura T; Fujishima M
    Clin Nephrol; 1997 Jun; 47(6):362-6. PubMed ID: 9202865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease.
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S1-199. PubMed ID: 9867706
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease in chronic renal failure. Risk factors and prevention.
    Henriquez D; Dikow R; Ritz E
    Nefrologia; 2004; 24 Suppl 4():34-9. PubMed ID: 15279384
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.